The transgenic construct contains a full length human dystrophin gene modified by the deletion of repeat 4 through repeat 23 and the C-terminus to generate a micro-dystrophin cDNA (deltaR16-17/deltaC) under the control of the human skeletal alpha 1 actin (ACTA1) promoter. (J:167308)